The epidemiology of sepsis in the United States from 1979 through 2000.
暂无分享,去创建一个
[1] M. Langer,et al. The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock , 1995, Intensive Care Medicine.
[2] D. Pittet,et al. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients , 1995, Intensive Care Medicine.
[3] Susan L Ettner,et al. Contribution of major diseases to disparities in mortality. , 2002, The New England journal of medicine.
[4] A. M. Fendrick,et al. Is sepsis accurately coded on hospital bills? , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[5] G. Martin,et al. The ICD-9 code for septicemia maintains a high positive predictive value for clinical sepsis , 2002 .
[6] J. le Gall,et al. Erratum to: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study , 2002, Intensive Care Medicine.
[7] Corinne Alberti,et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study , 2002, Intensive Care Medicine.
[8] S. Opal,et al. High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial , 2001 .
[9] K D Kochanek,et al. Deaths: final data for 1999. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[10] R. Wenzel,et al. Severe sepsis-national estimates. , 2001, Critical care medicine.
[11] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[12] J Ean,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.
[13] G. Rothe,et al. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: Gender-specific genetic predisposition to sepsis , 2001, Critical care medicine.
[14] R. Wenzel,et al. The impact of hospital-acquired bloodstream infections. , 2001, Emerging infectious diseases.
[15] R. Wenzel,et al. Managing antibiotic resistance. , 2000, The New England journal of medicine.
[16] D. Heyland,et al. Long-term health-related quality of life in survivors of sepsis. Short Form 36: A valid and reliable measure of health-related quality of life , 2000, Critical care medicine.
[17] J. A. Kruse,et al. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. , 2000, JAMA.
[18] Charles J. Fisher,et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation , 2000, Critical care medicine.
[19] C. Brun-Buisson,et al. The epidemiology of the systemic inflammatory response , 2000, Intensive Care Medicine.
[20] J. Dhainaut,et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. , 1999, JAMA.
[21] A. Hoeft,et al. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. , 1999, Critical care medicine.
[22] D C Angus,et al. Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop. , 1999, American journal of respiratory and critical care medicine.
[23] H. El‐Serag,et al. Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.
[24] A P Wheeler,et al. Treating patients with severe sepsis. , 1999, The New England journal of medicine.
[25] G. Bernard,et al. Results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research , 1999 .
[26] J. Vincent,et al. Has the mortality of septic shock changed with time. , 1998, Critical care medicine.
[27] T. Evans,et al. Comparison of nose and face mask CPAP therapy for sleep apnoea , 1998, Thorax.
[28] L. Iezzoni. Assessing Quality Using Administrative Data , 1997, Annals of Internal Medicine.
[29] D. Bates,et al. Epidemiology of sepsis syndrome in 8 academic medical centers. , 1997, JAMA.
[30] J. Vincent,et al. Dear SIRS, I'm sorry to say that I don't like you... , 1997, Critical care medicine.
[31] R. Wenzel,et al. Long-Term Survival and Function After Suspected Gram-Negative Sepsis , 1996 .
[32] F. Stüber,et al. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. , 1996, Critical care medicine.
[33] K. Steinberg,et al. Improved Survival of Patients with Acute Respiratory Distress Syndrome (ARDS): 1983???1993 , 1995 .
[34] François Gouin,et al. Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units , 1995 .
[35] F Doyon,et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.
[36] D. Pittet,et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.
[37] J. Verhoef,et al. The sepsis syndrome in a Dutch university hospital. Clinical observations. , 1993, Archives of internal medicine.
[38] Z. Yuan,et al. Alcohol-related hospitalizations of elderly people. Prevalence and geographic variation in the United States. , 1993, JAMA.
[39] J. Whittle,et al. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. , 1993, The New England journal of medicine.
[40] C. Beck-Sague,et al. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.
[41] A. Fein,et al. Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients. , 1993, JAMA.
[42] R. Bone,et al. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome) , 1992, JAMA.
[43] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[44] F. Ognibene,et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. , 1990, Annals of internal medicine.
[45] Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979-1987. , 1990, MMWR. Morbidity and mortality weekly report.
[46] Hsia Dc,et al. Accuracy of Diagnostic Coding for Medicare Patients under the Prospective-Payment System , 1988 .